Antifungal medicines are central to treating aspergillosis.
This hub includes information on itraconazole, voriconazole, posaconazole, amphotericin,
new antifungals in development, side-effects, drug levels and monitoring.
Aspergillosis Patient & Carer Support Provided by the NHS National Aspergillosis Centre
- About Aspergillosis
- Information & Support
- Carers & Family
- Supporting Someone with Aspergillosis: A Guide for Carers and Families
- Energy Pacing for Carers: Helping Someone with Aspergillosis Manage Their Energy
- Understanding Aspergillosis Medicines: A Guide for Carers
- Aspergillosis Carer Checklist: What to Watch For and What Helps
- When Someone with Aspergillosis Has a Bad Day: A Guide for Carers
- Health Information
- Damp homes
- Why are damp homes bad for our health?
- Health Hazards from Damp – What People with Aspergillosis Should Know
- Toxic Mould & Mycotoxins: What People With Aspergillosis Need to Know
- Preventing Damp in Your Home — A Guide for People with Aspergillosis
- Damp homes: UK Policy and Research 2025
- UK Government reports on housing safety and damp control 2025
- Tenant responsibilities
- Investigate timelines for landlord compliance under Awaab’s Law
- What actions can tenants take if landlords delay repairs
- Best practices for landlords to document tenant vulnerability details
- Find agencies or organizations that assist tenants with housing disputes
- Support
- Patient Polls
- UK Clinical trials for aspergillosis
- World Aspergillosis Day
- Carers & Family
- Aspergillosis Knowledge Hub
- ABPA (Allergic Bronchopulmonary Aspergillosis) Hub
- CPA (Chronic Pulmonary Aspergillosis) Hub
- Aspergillus Bronchitis Hub
- Vaccines Hub
- Travel & Insurance Hub
- Symptoms Hub
- Steroids & Tapering Hub
- SAFS / Severe Asthma with Fungal Sensitisation Hub
- Research Hub
- NAC News & Guidance Hub
- NAC Communities Hub
- Monitoring and Safety Hub
- Mental Health Hub
